Edition:
United States

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

1.26USD
26 May 2017
Change (% chg)

$0.01 (+0.80%)
Prev Close
$1.25
Open
$1.23
Day's High
$1.26
Day's Low
$1.23
Volume
9,922
Avg. Vol
13,817
52-wk High
$3.09
52-wk Low
$1.11

Select another date:

Wed, Apr 12 2017

BRIEF-Acasti Pharma says has successfully completed two Phase 1, two Phase 2 clinical trials with Capre

* Acasti Pharma Inc - has successfully completed two Phase 1 and two Phase 2 clinical trials with Capre for treatment of hypertriglyceridemia

BRIEF-Acasti Pharma provides update on Capre phase 3 development program

* Acasti Pharma provides update on Capre phase 3 development program

BRIEF-Acasti Pharma announces pricing for its public offering of units

* Acasti Pharma announces pricing for its public offering of units

BRIEF-Acasti Pharma Q3 loss C$0.22/shr

* Acasti pharma - Had cash,short-term investments of $5.8 million as of Nov 30, 2016

BRIEF-Acasti Pharma appoints Linda O'keefe as chief financial officer

* Acasti Pharma appoints Linda O'keefe as chief financial officer

Select another date:

More From Around the Web